Abbott Launches New Rapid Bacteria Test
Abbott, Abbott Park, Ill, has launched in the United States its Verax Platelet PGD test, a first-generation, single-use, rapid qualitative immunoassay test that detects bacteria in human platelets.
Read MoreAbbott, Abbott Park, Ill, has launched in the United States its Verax Platelet PGD test, a first-generation, single-use, rapid qualitative immunoassay test that detects bacteria in human platelets.
Read MorebioMrieux, Durham, NC, which specializes in the field of in vitro diagnostics, has spent millions in recent years upgrading its Durham facility as demand for medical testing equipment increases.
Read MoreLuminex Corp, Austin, Tex, a provider of multiplexed solutions, and Mayo Clinic, Rochester, Minn, have signed a development licensing agreement enabling Mayo to provide genetic and other testing services to patients using the company’s xMAP technology.
Read MoreBionas GmbH, Germany, which focuses on in vitro profiling of the metabolic activity of cells, reports that Pedro Mestres, a professor at Saarland University, Germany, has won second prize in a business plan contest for a novel drug sensitivity-screening tool based on Bionas technology.
Read MoreEfforts to create embryonic stem cells using cloning techniques should be put on hold for the time being, according to the Center for Genetics and Society, a public interest group.
Read More